The present invention includes nuclear receptor heterodimer and nuclear receptor-coactivator peptide assays for identifying ligands for nuclear receptors, utilizing scintillation proximity and fluorescence resonance energy transfer (FRET), and methods of using identified ligands.

 
Web www.patentalert.com

< Methods of prevention and treatment of inflammatory bowel disease

< Dimerizing agents, their production and use

> Methods and compositions for screening for altered cellular phenotypes

> 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives
~ 00230